NCT01040455View on ClinicalTrials.gov

Lansoprazole for Subgroups of Functional Dyspepsia

PHASE4TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Functional Dyspepsia
Interventions
DRUG

Lansoprazole

lansoprazole 15mg (Takepron®, Takeda Pharmaceutical Company, Osaka, Japan) once daily for eight weeks

DRUG

placebo

placebo once daily for eight weeks

Trial Locations (4)

100

National Taiwan University Hospital, Taipei

Unknown

National Taiwan University Hospital Yun-Lin Branch, Douliu

E-Da Hospital, Kaohsiung City

Veterans General Hospital-Taipei, Taipei

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

National Taiwan University Hospital

OTHER